![]() |
市場調查報告書
商品編碼
1634169
全球電外科設備市場 - 2025 - 2033Global Electrosurgical Devices Market - 2025 - 2033 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
2023年,全球電外科設備市場規模達62.7億美元,預計2033年將達91億美元,2025-2033年預測期間複合年成長率為3.7%。
電外科設備,也稱為 Bovie,是一種用於切割、透過乾燥破壞組織以及透過凝固血液控制出血的手術工具。它使用高功率發生器在探頭和手術部位之間產生射頻火花,造成局部加熱和組織損傷。此發生器以兩種模式運作:單極(主動電極將電流集中到該部位)和雙極(兩個電極都位於手術部位)。
驅動程式和限制
科技進步的崛起
技術進步極大地塑造了全球電外科設備市場,並提高了手術的精確度和安全性。這包括微創技術、機器人輔助系統和先進的基於能量的模式。這些進步可幫助醫療保健提供者實現更好的患者治療效果,同時減少恢復時間和併發症。智慧型系統和資料分析的整合改進了設備功能。隨著技術的發展,電外科設備在各個醫學學科中被採用,促進了市場的成長。
例如,2024 年8 月,Olympus在其PowerSeal 密封機/分隔器產品組合中推出了兩種新的鉗口設計:PowerSeal 彎曲鉗口,雙動(SJDA) 和PowerSeal 彎曲鉗口,單動(CJSA)。這些設備可支援手術期間的解剖、抓取和密封技術,提高手術效率和舒適度。奧林巴斯聲稱,與競爭對手的儀器相比,PowerSeal 設計需要更少的擠壓力來閉合鉗口,而不會影響鉗口力道或密封能力。這些一次性設備可用於腹腔鏡和開放性手術。
設備成本高
由於先進技術的成本高昂,全球電外科設備市場面臨挑戰,這對中低收入地區的醫療機構來說是一個重大障礙。這些成本,加上對專門培訓和技術專長的需求,可能會限制獲得最先進設備的機會。儘管有改善手術效果和效率的潛力,但這些設備的高成本可能會阻礙其廣泛採用。
例如,電外科設備的價格從 5000 美元到 15,000 美元不等,美國的知名品牌有 Covidien、Ellman 和 Erbe 等。美國以外最暢銷的品牌包括 Conmed 和 Sometech。新機和演示機比翻新機或二手機貴。新機器有製造商保固並且從未使用過,而演示機器是展覽模型。翻新機器經過改進,可以在製造商的工廠或私人維修店進行
The global electrosurgical devices market reached US$ 6.27 billion in 2023 and is expected to reach US$ 9.10 billion by 2033, growing at a CAGR of 3.7% during the forecast period 2025-2033.
The electrosurgical unit, also known as the Bovie, is a surgical tool used to incise, destroy tissue through desiccation, and control bleeding by coagulating blood. It uses a high-powered generator to produce a radiofrequency spark between a probe and the surgical site, causing localized heating and tissue damage. The generator operates in two modes: monopolar, where an active electrode concentrates current to the site, and bipolar, where both electrodes are located at the surgical site.
Market Dynamics: Drivers & Restraints
Rise in Technological Advancements
Technological advancements have significantly shaped the global electrosurgical devices market, enhancing precision and safety in procedures. This includes minimally invasive techniques, robotic-assisted systems, and advanced energy-based modalities. These advancements help healthcare providers achieve better patient outcomes with reduced recovery times and complications. The integration of intelligent systems and data analytics has improved device functionality. As technology evolves, electrosurgical devices are adopted across various medical disciplines, contributing to the market's growth.
For instance, in August 2024, Olympus has introduced two new jaw designs in its PowerSeal sealer/divider portfolio: the PowerSeal Curved Jaw, double-action (SJDA) and PowerSeal Curved Jaw, single-action (CJSA). These devices support dissection, grasping, and sealing techniques during surgery, promoting procedural efficiency and comfort. Olympus claims that the PowerSeal design requires less squeeze force than competitor instruments to close the jaws, without compromising jaw force or sealing capability. These single-use devices can be used in laparoscopic and open surgery.
High Cost of the Devices
The global electrosurgical devices market faces challenges due to the high cost of advanced technologies, a significant barrier for healthcare facilities in low- and middle-income regions. These costs, coupled with the need for specialized training and technical expertise, can limit access to state-of-the-art equipment. Despite the potential to improve surgical outcomes and efficiency, the high cost of these devices may hinder their widespread adoption.
For instance, Electrosurgical devices can range from $5000 to $15,000 USD, with well-known brands like Covidien, Ellman, and Erbe in the US. Top-selling brands outside the US include Conmed and Sometech. New and demo machines are more expensive than refurbished or used ones. New machines have a manufacturer's warranty and are never used, while demo machines are exhibition models. Refurbished machines have undergone improvements and can be done at the manufacturer's facilities or private repair shops
The global electrosurgical devices market is segmented based on product type, application, end user and region.
Electrosurgical Instruments segment is expected to dominate the Electrosurgical Devices market share
The electrosurgical instruments segment holds a major portion of the electrosurgical devices market share and is expected to continue to hold a significant portion of the electrosurgical devices market share during the forecast period.
Electrosurgical instruments, including electrodes, forceps, scissors, and probes, are crucial for precision and minimal tissue damage in various surgical procedures. They are versatile and used in general surgery, gynecology, urology, and orthopedics. Innovations in design, like non-stick coatings and ergonomics, enhance their effectiveness and safety. As demand for minimally invasive procedures increases, the adoption of advanced electrosurgical instruments is expected to drive market expansion, meeting healthcare providers' needs for reliable and efficient surgical tools.
For instance, in January 2023, Cook Medical has introduced a new, streamlined portfolio of urological bipolar electrodes in the U.S., focusing on the most frequently used products for bladder and prostate procedures. The portfolio includes seven products, six of which are specifically designed for transurethral resection, ablation, and soft tissue removal of the prostate and bladder, and where hemostasis is required. The streamlined portfolio is designed to meet the needs of urologists in the field.
General Surgery segment is the fastest-growing segment in Electrosurgical Devices market share
The general surgery segment is the fastest-growing segment in the electrosurgical devices market share and is expected to hold the market share over the forecast period.
The global electrosurgical devices market is primarily driven by general surgery, which uses these tools for cutting, coagulating, and tissue ablation. These devices offer precision and efficiency, reducing recovery time, blood loss, and complications. As conditions like hernias, appendicitis, and gastrointestinal disorders increase, the demand for electrosurgical devices in general surgery is expected to grow. Advancements in electrosurgical technologies further enhance their application in general surgery, solidifying their critical role in this market segment.
For instance, in 2023, as per NCBI study in the US found that 1 in 9 US households had undergone at least one surgical procedure in the past year, with the highest prevalence among those 65 and older and Medicare beneficiaries, with approximately 1 in 5 reporting such procedures.
North America holds a substantial position in the electrosurgical devices market and is expected to hold most of the market share due to significant investments in medical technologies, and high prevalence of chronic diseases. The region's strong base of leading medical device manufacturers and research institutions drives innovation in electrosurgical technologies. Government initiatives like favorable reimbursement policies and funding for medical advancements contribute to market growth. The widespread adoption of minimally invasive surgical procedures and skilled healthcare professionals further enhance the use of electrosurgical devices.
For instance, in June 2023, Olympus Corporation has announced the availability of its latest electrosurgical generator, the ESG-410, for treating bladder cancer and enlarged prostate. This next-generation generator offers efficiencies in treating NMIBC (non-muscle-invasive bladder cancer) and BPH (enlarged prostate), using various resection loops, band electrodes, and vaporization buttons and needles. The generator supports options and efficiencies in the treatment of these conditions.
Europe is growing at the fastest pace in the Electrosurgical Devices market
Europe holds the fastest pace in the electrosurgical devices market and is expected to hold most of the market share due to established healthcare system and robust regulatory frameworks. The region's focus on improving surgical outcomes and patient safety has led to widespread adoption of advanced electrosurgical technologies. The growing aging population and increasing incidence of chronic diseases like diabetes, cancer, and cardiovascular conditions increase the demand for surgical procedures. Europe's leading medical device manufacturers and research organizations contribute to technological advancements and product development. Government initiatives, reimbursement policies, training programs, and collaborations between healthcare providers and manufacturers further drive market growth.
For instance, in November 2024, Halma PLC has acquired Lamidey Noury Medical for EUR50 Billion, aiming to expand its Healthcare sector. The Paris-based electrosurgical device firm, which is used in urology, gynaecology, and general surgery, is a minimally invasive option used in over 60 countries. The acquisition is funded by existing lending facilities. LNM generated EUR13.6 billion in revenue from the 12 months to October, meeting Halma's target range of 19% to 23%.
The major global players in the electrosurgical devices market include Stryker Corporation, Boston Scientific Corporation, Symmetry Surgical Inc, CONMED Corporation, Medtronic Plc, Ethicon (Johnson and Johnson), B. Braun SE, Smith+Nephew, Olympus Corporation, Abbott Laboratories, OTTek, Dalent Medical, MMI, EGDe Surgical and among others.
The global electrosurgical devices market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.
LIST NOT EXHAUSTIVE